|
1
|
Landau RL: Landmark perspective: Treatment
of hyperthyroidism. JAMA. 251:1747–1748. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Glinoer D and Cooper DS: The
propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes.
19:402–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malozowski S and Chiesa A:
Propylthiouracil-induced hepatotoxicity and death. Hopefully, never
more. J Clin Endocrinol Metab. 95:3161–3163. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang J, Li LF, Xu Q, Zhang J, Weng WW, Zhu
YJ and Dong MJ: Analysis of 90 cases of antithyroid drug-induced
severe hepatotoxicity over 13 years in China. Thyroid. 25:278–283.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang MT, Lee WJ, Huang TY, Chu CL and
Hsieh CH: Antithyroid drug-related hepatotoxicity in
hyperthyroidism patients: A population-based cohort study. Br J
Clin Pharmacol. 78:619–629. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu DB, Chen EQ, Bai L and Tang H:
Propylthiouracil-induced liver failure and artificial liver support
systems: A case report and review of the literature. Ther Clin Risk
Manag. 13:65–68. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bahn RS, Burch HS, Cooper DS, Garber JR,
Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross
D, et al: The role of propylthiouracil in the management of graves'
disease in adults: Report of a meeting jointly sponsored by the
american thyroid association and the food and drug administration.
Thyroid. 19:673–674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Williams KV, Nayak S, Becker D, Reyes J
and Burmeister LA: Fifty years of experience with
propylthiouracil-associated hepatotoxicity: What have we learned? J
Clin Endocrinol Metab. 82:1727–1733. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maeda S and Tsukihara T: Structure of the
gap junction channel and its implications for its biological
functions. Cell Mol Life Sci. 68:1115–1129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sosinsky GE and Nicholson BJ: Structural
organization of gap junction channels. Biochim Biophys Acta.
1711:99–125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Harris AL: Emerging issues of connexin
channels: Biophysics fills the gap. Q Rev Biophys. 34:325–472.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Koffler LD, Fernstrom MJ, Akiyama TE,
Gonzalez FJ and Ruch RJ: Positive regulation of connexin32
transcription by hepatocyte nuclear factor-1alpha. Arch Biochem
Biophys. 407:160–167. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zoidl G and Dermietzel R: Gap junctions in
inherited human disease. Pflugers Arch. 460:451–466. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scott DA, Kraft ML, Stone EM, Sheffield VC
and Smith RJ: Connexin mutations and hearing loss. Nature.
391:321998. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Belousov AB, Fontes JD, Freitas-Andrade M
and Naus CC: Gap junctions and hemichannels: Communicating cell
death in neurodevelopment and disease. BMC Cell Biol. 18 (Suppl
1):42017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park WJ, Park JW, Erez-Roman R,
Kogot-Levin A, Bame JR, Tirosh B, Saada A, Merrill AH Jr,
Pewzner-Jung Y and Futerman AH: Protection of a ceramide synthase 2
null mouse from drug-induced liver injury: Role of gap junction
dysfunction and connexin 32 mislocalization. J Biol Chem.
288:30904–30916. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maurel M and Rosenbaum J: Closing the gap
on drug-induced liver injury. Hepatology. 56:781–783. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Naiki-Ito A, Asamoto M, Naiki T, Ogawa K,
Takahashi S, Sato S and Shirai T: Gap junction dysfunction reduces
acetaminophen hepatotoxicity with impact on apoptotic signaling and
connexin 43 protein induction in rat. Toxicol Pathol. 38:280–286.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patel SJ, Milwid JM, King KR, Bohr S,
Iracheta-Vellve A, Li M, Vitalo A, Parekkadan B, Jindal R and
Yarmush ML: Gap junction inhibition prevents drug-induced liver
toxicity and fulminant hepatic failure. Nat Biotechnol. 30:179–183.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Asamoto M, Hokaiwado N, Murasaki T and
Shirai T: Connexin 32 dominant-negative mutant transgenic rats are
resistant to hepatic damage by chemicals. Hepatology. 40:205–210.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang F, Li S, Gan X, Wang R and Chen Z:
Propofol inhibits gap junctions by attenuating sevoflurane-induced
cytotoxicity against rat liver cells in vitro. Eur J Anaesthesiol.
31:219–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Q, You T, Yuan D, Han X, Hong X, He
B, Wang L, Tong X, Tao L and Harris AL: Cisplatin and oxaliplatin
inhibit gap junctional communication by direct action and by
reduction of connexin expression, thereby counteracting cytotoxic
efficacy. J Pharmacol Exp Ther. 333:903–911. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang N, Liu J, Chen B, Zhang Y, Yu M, Cai
Z and Chen H: Effects of gap junction intercellular communication
on the docetaxel-induced cytotoxicity in rat hepatocytes. Mol Med
Rep. 15:2689–2694. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang R, Huang F, Chen Z and Li S:
Downregulation of connexin 32 attenuates hypoxia/reoxygenation
injury in liver cells. J Biochem Mol Toxicol. 29:189–197. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong X, Wang Q, Yang Y, Zheng S, Tong X,
Zhang S, Tao L and Harris AL: Gap junctions propagate opposite
effects in normal and tumor testicular cells in response to
cisplatin. Cancer Lett. 317:165–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Tao L, Fan L, Peng Y, Yang K,
Zhao Y, Song Q and Wang Q: Different gap junction-propagated
effects on cisplatin transfer result in opposite responses to
cisplatin in normal cells versus tumor cells. Sci Rep. 5:125632015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang N, Chen H, Cai Z, Zhan P, Pan T,
Zhang Y and Wu X: Development and validation of RP-HPLC method for
determination of propylthiouracil in hepatic cells. Curr Pharm
Anal. 14:219–222. 2018. View Article : Google Scholar
|
|
28
|
Tian YY, An LJ, Jiang L, Duan YL, Chen J
and Jiang B: Catalpol protects dopaminergic neurons from
LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Life Sci. 80:193–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Davidson JS and Baumgarten IM:
Glycyrrhetinic acid derivatives: A novel class of inhibitors of
gap-junctional intercellular communication. Structure-activity
relationships. J Pharmacol Exp Ther. 246:1104–1107. 1988.PubMed/NCBI
|
|
30
|
Vrionis FD, Wu JK, Qi P, Waltzman M,
Cherington V and Spray DC: The bystander effect exerted by tumor
cells expressing the herpes simplex virus thymidine kinase (HSVtk)
gene is dependent on connexin expression and cell communication via
gap junctions. Gene Ther. 4:577–585. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hamada N, Matsumoto H, Hara T and
Kobayashi Y: Intercellular and intracellular signaling pathways
mediating ionizing radiation-induced bystander effects. J Radiat
Res. 48:87–95. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prise KM and O'Sullivan JM:
Radiation-induced bystander signalling in cancer therapy. Nat Rev
Cancer. 9:351–360. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krutovskikh VA, Piccoli C and Yamasaki H:
Gap junction intercellular communication propagates cell death in
cancerous cells. Oncogene. 21:1989–1999. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Krysko DV, Leybaert L, Vandenabeele P and
D'Herde K: Gap junctions and the propagation of cell survival and
cell death signals. Apoptosis. 10:459–469. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin JH, Weigel H, Cotrina ML, Liu S, Bueno
E, Hansen AJ, Hansen TW, Goldman S and Nedergaard M:
Gap-junction-mediated propagation and amplification of cell injury.
Nat Neurosci. 1:7431998. View
Article : Google Scholar
|
|
36
|
Decrock E, Krysko DV, Vinken M, Kaczmarek
A, Crispino G, Bol M, Wang N, De Bock M, De Vuyst E, Naus CC, et
al: Transfer of IP3 through gap junctions is critical, but not
sufficient, for the spread of apoptosis. Cell Death Differ.
19:947–957. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Decrock E, Vinken M, Bol M, D'Herde K,
Rogiers V, Vandenabeele P, Krysko DV, Bultynck G and Leybaert L:
Calcium and connexin-based intercellular communication, a deadly
catch? Cell Calcium. 50:310–321. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Niessen H, Harz H, Bedner P, Krämer K and
Willecke K: Selective permeability of different connexin channels
to the second messenger inositol 1,4,5-trisphosphate. J Cell Sci.
113:1365–1372. 2000.PubMed/NCBI
|
|
39
|
Goldberg GS, Moreno AP and Lampe PD: Gap
junctions between cells expressing connexin 43 or 32 show inverse
permselectivity to adenosine and ATP. J Biol Chem. 277:36725–36730.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bevans CG, Kordel M, Rhee SK and Harris
AL: Isoform composition of connexin channels determines selectivity
among second messengers and uncharged molecules. J Biol Chem.
273:2808–2816. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kariya K, Sawahata T, Okuno S and Lee E:
Inhibition of hepatic glutathione transferases by propylthiouracil
and its metabolites. Biochem Pharmacol. 35:1475–1479. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ye J, Zhong X, Du Y, Cai C and Pan T: Role
of levothyroxine and vitamin E supplementation in the treatment of
oxidative stress-induced injury and apoptosis of myocardial cells
in hypothyroid rats. J Endocrinol Invest. 40:713–719. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tas S, Dirican M, Sarandöl E and Serdar Z:
The effect of taurine supplementation on oxidative stress in
experimental hypothyroidism. Cell Biochem Funct. 24:153–158. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schattenberg JM, Wang Y, Rigoli RM, Koop
DR and Czaja MJ: CYP2E1 overexpression alters hepatocyte death from
menadione and fatty acids by activation of ERK1/2 signaling.
Hepatology. 39:444–455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zheng L, Wang C, Luo T, Lu B, Ma H, Zhou
Z, Zhu D, Chi G, Ge P and Luo Y: JNK activation contributes to
oxidative stress-induced parthanatos in glioma cells via increase
of intracellular ROS production. Mol Neurobiol. 54:3492–3505. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Muriel P: Role of free radicals in liver
diseases. Hepatol Int. 3:526–536. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Luo C, Yuan D, Li X, Yao W, Luo G, Chi X,
Li H, Irwin MG, Xia Z and Hei Z: Propofol attenuated acute kidney
injury after orthotopic liver transplantation via inhibiting gap
junction composed of connexin 32. Anesthesiology. 122:72–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
